Menu
  • About RedHill
  • Products
  • Partnering
  • Investors
  • News
  • Contact
  • CAREERS
  • Press Releases

    Date Summary View
    Toggle Summary Egalet and RedHill Biopharma enter into License Agreement
    Egalet and RedHill Biopharma enter into an exclusive license agreement to develop, and commercialize Egalet’s EG-P042 (Carvedilol) for the treatment of certain cardiac diseases ...
    View HTML